Abstracts tagged "quality of care and rheumatoid arthritis (RA)"

Abstract Number: 2960 • 2018 ACR/ARHP Annual Meeting
Evaluation of Performance Measures Reveals Delays and Sub-Optimal Access to Rheumatology Care and Treatment
Claire Barber¹, Diane Lacaille², Peter Faris³, Dianne P. Mosher⁴, Steven J. Katz⁵, Joanne Homik⁶, Jatin Patel⁷, Sharon Zhang⁷, Cheryl Barnabe⁸, Glen Hazlewood⁹, Vandana Ahluwalia¹⁰, Natalie J. Shiff¹¹, Vivian P. Bykerk¹², Marinka Twilt¹³, Susanne Benseler¹⁴, Jennifer Burt¹⁵ and Deborah A. Marshall¹⁶, ¹Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, ²Arthritis Research Canada/University of British Columbia, Medicine/Rheumatology, Richmond, BC, Canada, ³Alberta Health Services, Alberta, AB, Canada, ⁴Med, University of Calgary, Calgary, AB, Canada, ⁵Rheumatology, University of Alberta, Edmonton, AB, Canada, ⁶University of Alberta, Edmonton, AB, Canada, ⁷Alberta Health Services, Calgary, AB, Canada, ⁸Medicine, University of Calgary, Calgary, AB, Canada, ⁹Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada, ¹⁰William Osler Health Center, Brampton, ON, Canada, ¹¹University of Florida, Gainesville, FL, ¹²Deptartment of Rheumatology, Hospital for Special Surgery, New York, NY, ¹³University of Calgary, Calgary, AB, Canada, ¹⁴Pediatric Rheumatology, University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada, ¹⁵St. Clare's Mercy Hospital, Eastern Health, St. John's, NF, Canada, ¹⁶Community Health Sciences, University of Calgary, Calgary, AB, Canada
Background/Purpose: Early diagnosis, treatment and ongoing care are critical to optimize RA outcomes. The purpose of the study was to evaluate key elements of RA…
Abstract Number: 1166 • 2016 ACR/ARHP Annual Meeting
Survey on the Understanding and Practice of T2T for Nurses Engaged in Medical Treatment of Rheumatoid Arthritis
Mie Fusama¹, Kayoko Higashi¹, Keiji Maeda², Norikazu Murata³ and Hideko Nakahara², ¹Division of Nursing, NTT West Osaka Hospital, Osaka, Japan, ²NTT West Osaka Hospital, Osaka, Japan, ³Yukioka Hospital, Osaka, Japan
Background/Purpose: In order to achieve treatment goals in patients with rheumatoid arthritis (RA), the guidance for “treatment to target (T2T) by measuring disease activity and…
Abstract Number: 1492 • 2015 ACR/ARHP Annual Meeting
Implementation in Clinical Practice of a Medication Assessment Tool Specific for Rheumatoid Arthritis, Rhmat
Louise Grech^1,2, Anthony Serracino Inglott¹, Victor Ferrito¹ and Lilian M. Azzopardi¹, ¹Department of Pharmacy, University of Malta, Msida, Malta, ²Clinical Pharmacy Practice Unit, Department of Pharmacy, Mater Dei Hospital, Msida, Malta
Background/Purpose: The RhMAT is a medication assessment tool developed to specifically analyse pharmacotherapy adherence to evidence based medicine and guidelines on the management of rheumatoid…
Abstract Number: 2306 • 2014 ACR/ARHP Annual Meeting
Quality of Care for Cardiovascular Prevention in RA: Compliance with Diabetes Screening Guidelines
Timothy J Schmidt^1,2, J Antonio Avina-Zubieta^2,3,4, Eric C. Sayre³, Michal Abrahamowicz⁵, John M. Esdaile^2,6,7 and Diane Lacaille^8,9,10, ¹Arthritis Research Centre of Canada, Richmind, BC, Canada, ²Experimental Medicine, University of British Columbia, Department of Experimental Medicine, Vancouver, BC, Canada, ³Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁴Medicine, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, ⁵Division of Clinical Epidemiology, McGill University, Montreal, QC, Canada, ⁶Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁷Rheumatology, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, ⁸Arthritis Research Centre of Canada, Vancouver, BC, Canada, ⁹Medicine, University of British Columbia, Vancouver, BC, Canada, ¹⁰University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada
Background/Purpose: Comorbidities are increasingly recognized as significant contributors of decreased quality of life, and increased mortality in RA. RA is associated with an increased risk…
Abstract Number: 2308 • 2014 ACR/ARHP Annual Meeting
Quality of Care for Cardiovascular Disease Prevention in RA: Compliance Lipid Screening Guidelines
Timothy J Schmidt^1,2, J Antonio Avina-Zubieta^3,4,5, Eric C. Sayre⁴, Michal Abrahamowicz⁶, John M. Esdaile^3,7,8 and Diane Lacaille^9,10,11, ¹Arthritis Research Centre of Canada, Richmind, BC, Canada, ²Experimental Medicine, University of British Columbia, Department of Experimental Medicine, Richmond, BC, Canada, ³Experimental Medicine, University of British Columbia, Department of Experimental Medicine, Vancouver, BC, Canada, ⁴Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁵Medicine, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, ⁶Division of Clinical Epidemiology, McGill University, Montreal, QC, Canada, ⁷Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁸Rheumatology, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, ⁹Medicine, University of British Columbia, Vancouver, BC, Canada, ¹⁰Arthritis Research Centre of Canada, Vancouver, BC, Canada, ¹¹University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada
Background/Purpose: Comorbidities are increasingly recognized as significant contributors of reduced quality of life and increased mortality in RA. Cardiovascular diseases are the leading cause of…
Abstract Number: 1351 • 2014 ACR/ARHP Annual Meeting
Assessment of ACR Endorsed Quality Indicators in Rheumatoid Arthritis Patients – a Quality Improvement Initiative
Puneet Bajaj¹, Erik Anderson², Siddharth Raghavan², Asha Patnaik¹ and Heidi Roppelt¹, ¹Rheumatology, Stony Brook University Medical Center, East Setauket, NY, ²Internal Medicine, Stony Brook University Medical Center, East Setauket, NY
Background/Purpose: Quality assessments are being increasingly used for quality improvement, accountability, and performance based incentives. The current research regarding quality of care provided to rheumatoid…
Abstract Number: 1350 • 2014 ACR/ARHP Annual Meeting
Practice What You Preach? Suboptimal Guideline Adherence By Rheumatologists in Patients with Rheumatoid Arthritis
Nienke Lesuis¹, Ronald van Vollenhoven², Marlies Hulscher³ and Alfons den Broeder¹, ¹Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, ²Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute, Stockholm, Sweden, ³IQ Healthcare, Radboud University Medical Centre, Nijmegen, Netherlands
Background/Purpose: Tight control based treatment principles of rheumatoid arthritis (RA) are superior to usual care and therefore recommended in many (inter)national guidelines.1-3 Unfortunately guideline adherence…
Abstract Number: 1711 • 2013 ACR/ARHP Annual Meeting
Folic Acid Prescription Among Older Adult Methotrexate Initiators Is Poor
Gabriela Schmajuk¹, Jinoos Yazdany², Yinghui Miao³, David I. Daikh⁴ and Michael Steinman³, ¹Rheumatology, UCSF / San Francisco VA Medical Center, San Francisco, CA, ²Medicine, University of California, San Francisco, San Francisco, CA, ³Division of Geriatrics, UCSF, San Francisco Veterans Affairs Medical Center, San Francisco, CA, ⁴Rheumatology, University of California, San Francisco, San Francisco, CA
Background/Purpose: Methotrexate (MTX) is the most commonly used disease modifying agent for rheumatoid arthritis (RA), although liver enzyme (LFT) elevations limit its use in some…
Abstract Number: 1667 • 2012 ACR/ARHP Annual Meeting
Impact of Rheumatoid Arthritis On Recognition of Hypertension in a Medically Homed Population
Christie M. Bartels¹, Heather Johnson², Katya Voelker³, Patrick Mc Bride⁴ and Maureen Smith⁵, ¹Rheumatology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, ²Cardiology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, ³Univ of Wisconsin School of Medicine and Public Health, Madison, AA, ⁴Cardiology/Medicine, Univ of Wisconsin School of Medicine and Public Health, Madison, WI, ⁵Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI
Impact of Rheumatoid Arthritis on Recognition of Hypertension in a Medically Homed PopulationBackground/Purpose: Numerous studies report increased cardiovascular disease (CVD) events and others describe increased…
Abstract Number: 2511 • 2012 ACR/ARHP Annual Meeting
Potential Barriers That Limit Access to Rheumatologists Among Patients with Early Rheumatoid Arthritis in a Universal Access Health Care System
Jessica Widdifield¹, J. Michael Paterson², Sasha Bernatsky³, Karen Tu², Nadia Gunraj², Noah Ivers¹, Debra Butt², R. Liisa Jaakkimainen⁴, J. Carter Thorne⁵, Vandana Ahluwalia⁶ and Claire Bombardier⁷, ¹University of Toronto, Toronto, ON, Canada, ²Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, ³Clinical Epidemiology, Research Institute of the McGill University Health Ctre, Montreal, QC, Canada, ⁴Preventive Med and Biostatisti, University of Toronto, Toronto, ON, Canada, ⁵Southlake Regional Health Centre, Newmarket, ON, Canada, ⁶William Osler Health Center, Brampton, ON, Canada, ⁷Rheumatology, University of Toronto, Toronto, ON, Canada
Background/Purpose: Current guidelines for the optimal care of rheumatoid arthritis (RA) recommend prompt referral to a rheumatologist. In the province of Ontario, Canada all 13…
Abstract Number: 2061 • 2012 ACR/ARHP Annual Meeting
Physician Variation in Documentation of Rheumatoid Arthritis Quality Measures and Evaluation of Relationship with Radiographic Progression
Sonali Desai¹, Jinoos Yazdany², Nancy A. Shadick³, Siri Lillegraven⁴, Chih-Chin Liu⁵, Michelle A. Frits⁶, Tabatha Norton⁷, Jonathan S. Coblyn⁸, Michael Weinblatt⁵ and Daniel H. Solomon⁹, ¹Medicine/ Rheumatology, Boston, MA, ²Medicine, University of California, San Francisco, San Francisco, CA, ³Rheumatology/Immunology, Brigham and Women's Hospital, Boston, MA, ⁴Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁵Rheumatology & Immunology, Brigham & Women's Hospital, Boston, MA, ⁶Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ⁷Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ⁸Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ⁹Division of Rheumatology, Brigham and Women's Hospital, Boston, MA
Background/Purpose: Documentation of quality measures (QMs) in rheumatoid arthritis (RA) has been proposed as a way to demonstrate quality of care, but data linking appropriate…
Abstract Number: 2051 • 2012 ACR/ARHP Annual Meeting
Standardized Data Collection Supports Reliable Reporting of Rheumatoid Arthritis (RA) Measures for the Medicare Physicians’ Quality Reporting System
J. Timothy Harrington¹, George Reed², Katherine C. Saunders³, Lisa Lemire⁴, Aimee Whitworth⁴, Jeffrey D. Greenberg⁵ and Joel M. Kremer⁶, ¹Joiner Associates LLC, Madison, WI, ²Division of Behavioral and Preventive Medicine, University of Massachusetts Medical School, Worcester, MA, ³Corrona, LLC., Southborough, MA, ⁴CORRONA, Inc., Southborough, MA, ⁵New York Hospital for Joint Disease, New York, NY, ⁶Albany Medical College and The Center for Rheumatology, Albany, NY
Background/Purpose: The Medicare Physicians' Quality Reporting System (PQRS) program encourages physicians to measure and report clinical processes and disease outcomes that correlate with quality care,…
Abstract Number: 1822 • 2012 ACR/ARHP Annual Meeting
Liver Toxicity Monitoring and Its Impact On Methotrexate Discontinuation in a National Cohort of Veterans
Gabriela Schmajuk¹, Yinghui Miao², Jinoos Yazdany³, Mary Margaretten⁴ and Michael Steinman², ¹Rheumatology, UCSF / San Francisco VA Medical Center, San Francisco, CA, ²Division of Geriatrics, UCSF, San Francisco Veterans Affairs Medical Center, San Francisco, CA, ³Medicine, University of California, San Francisco, San Francisco, CA, ⁴Rheumatology, University of California, San Francisco, San Francisco, CA
Background/Purpose: The National Quality Forum recently endorsed a controversial quality measure that assesses liver toxicity monitoring for patients receiving oral methotrexate (MTX). Using national data…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].